drugset / Trial / NCT07504198

Neuroprotection of Memantine and Rosuvastatin

NCT07504198

Phase 2/3 Not yet recruiting 46 enrolled Tanta University
RandomizedParallel-groupSingle-blindPrevention

Summary

Memantine is used to slow the neurotoxicity of Alzheimer disease. Rosuvastatin used as a lipid-lowering agent . Increased bioavailability of endothelial-derived nitric oxide improves endothelium function , increases cerebral blood flow which may all contribute to the neuroprotective effects of rosuvastatin . The goal of this clinical trial is to prevent oxaliplatin induced peripheral neuropathy in patients with colorectal cancer.The aim of this current study is to assess the neuroprotective effect of memantine and rosuvastatin against oxaliplatin induced peripheral neuropathy.

Timeline

Start
2026-03
Primary completion
2027-04
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 20 mg Oral
Comparator Rosuvastatin Small molecule 20 mg Oral

Indications